Table 3.
Evolution of vessel-wall contrast enhancement on follow-up
| Follow-up interval | Complete resolution of VW-CE | Partial regression of VW-CE | Stability of VW-CE | Progression of VW-CE |
|---|---|---|---|---|
| Entire Follow-up* (N = 48)** | 13 (27.1%) | 14 (29.2%) | 17 (35.4%) | 4 (8.3%) |
| Short-term (N = 34)** | 2 (5.9%) | 12 (35.3%) | 19 (55.9%) | 1 (2.9%) |
| Mid-term (N = 22)** | 7 (31.8%) | 9 (40.9%) | 6 (27.3%) | 0 (0%) |
| Long-term (N = 21)** | 8 (38.1%) | 6 (28.6%) | 3 (14.3%) | 4 (19.0%) |
VW-CE vessel wall contrast enhancement
*Comparison of the initial MRI scan with the last available MRI scan of each patient
**Number of evaluated VW-CE lesions